A complex with poly(A)-binding protein and EWS facilitates the transcriptional function of oncogenic ETS transcription factors in prostate cells.

ERG ETS factor EWS PABPC1 prostate cancer transcription

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
11 Nov 2023
Historique:
received: 14 03 2023
revised: 21 10 2023
accepted: 25 10 2023
pubmed: 14 11 2023
medline: 14 11 2023
entrez: 13 11 2023
Statut: aheadofprint

Résumé

The ETS transcription factor ERG is aberrantly expressed in approximately 50% of prostate tumors due to chromosomal rearrangements such as TMPRSS2/ERG. The ability of ERG to drive oncogenesis in prostate epithelial cells requires interaction with distinct coactivators, such as the RNA-binding protein EWS. Here, we find that ERG has both direct and indirect interactions with EWS, and the indirect interaction is mediated by the poly-A RNA-binding protein PABPC1. PABPC1 directly bound both ERG and EWS. ERG expression in prostate cells promoted PABPC1 localization to the nucleus and recruited PABPC1 to ERG/EWS-binding sites in the genome. Knockdown of PABPC1 in prostate cells abrogated ERG-mediated phenotypes and decreased the ability of ERG to activate transcription. These findings define a complex including ERG and the RNA-binding proteins EWS and PABPC1 that represents a potential therapeutic target for ERG-positive prostate cancer and identify a novel nuclear role for PABPC1.

Identifiants

pubmed: 37956771
pii: S0021-9258(23)02481-X
doi: 10.1016/j.jbc.2023.105453
pmc: PMC10704431
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105453

Subventions

Organisme : NCI NIH HHS
ID : R01 CA204121
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002529
Pays : United States

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Références

Cell Growth Differ. 1996 Apr;7(4):429-37
pubmed: 9052984
Genome Biol. 2022 Apr 26;23(1):105
pubmed: 35473573
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8584-8592
pubmed: 32220959
PLoS One. 2020 Sep 11;15(9):e0238999
pubmed: 32915889
Mol Cell Biol. 1993 Dec;13(12):7393-8
pubmed: 8246959
J Clin Invest. 1994 Aug;94(2):489-96
pubmed: 8040301
PLoS One. 2015 Jul 15;10(7):e0128495
pubmed: 26176602
J Biol Chem. 1998 May 22;273(21):13015-21
pubmed: 9582337
Exp Cell Res. 1994 Apr;211(2):400-7
pubmed: 7908267
Mol Cell Biol. 2006 Apr;26(8):3085-97
pubmed: 16581783
Biochemistry. 2018 Dec 26;57(51):7021-7032
pubmed: 30488693
Oncogene. 2015 Jul;34(29):3815-25
pubmed: 25263440
Nucleic Acids Res. 2014 Oct 29;42(19):11928-40
pubmed: 25294825
Nat Genet. 2009 May;41(5):619-24
pubmed: 19396168
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5752-6
pubmed: 8516324
Genes Dev. 2015 Sep 15;29(18):1915-29
pubmed: 26385962
Nat Struct Mol Biol. 2010 Nov;17(11):1358-66
pubmed: 20972445
NAR Cancer. 2021 Jan 27;3(1):zcaa046
pubmed: 33554122
Cell. 2017 Sep 21;171(1):163-178.e19
pubmed: 28844694
Nucleic Acids Res. 2014 Jul;42(13):e105
pubmed: 24878920
Oncogene. 2001 Sep 10;20(40):5747-54
pubmed: 11607824
J Mol Cell Biol. 2009 Dec;1(2):82-92
pubmed: 19783543
PLoS Genet. 2021 Jul 27;17(7):e1009708
pubmed: 34314419
J Biol Chem. 2017 Oct 20;292(42):17225-17235
pubmed: 28887309
J Virol. 2013 Jan;87(1):243-56
pubmed: 23077296
Nat Commun. 2018 Jan 2;9(1):10
pubmed: 29295980
Mol Cell Biol. 1998 Mar;18(3):1489-97
pubmed: 9488465
NAR Genom Bioinform. 2020 Mar;2(1):lqaa006
pubmed: 32051932
Biochim Biophys Acta. 2004 May 25;1678(2-3):67-84
pubmed: 15157733
Genes Dev. 2011 Oct 15;25(20):2147-57
pubmed: 22012618
EMBO J. 2007 Mar 21;26(6):1591-601
pubmed: 17318186
Biochem Soc Trans. 2015 Dec;43(6):1277-84
pubmed: 26614673
Mol Cell. 2011 Aug 5;43(3):353-68
pubmed: 21816343
Cell Rep. 2016 Oct 25;17(5):1289-1301
pubmed: 27783944
Nat Cell Biol. 2020 Oct;22(10):1187-1196
pubmed: 32929202
Nature. 2007 Aug 2;448(7153):595-9
pubmed: 17671502
Neoplasia. 2008 Feb;10(2):177-88
pubmed: 18283340
Science. 2005 Oct 28;310(5748):644-8
pubmed: 16254181
Biochem Biophys Res Commun. 2000 Dec 20;279(2):401-6
pubmed: 11118299
Cell Commun Signal. 2015 Feb 19;13:12
pubmed: 25885538
Cancer Res. 2001 Mar 15;61(6):2690-5
pubmed: 11289149
Oncogene. 1998 Aug 6;17(5):603-10
pubmed: 9704926
Front Genet. 2020 Mar 06;11:199
pubmed: 32211031
Brief Funct Genomic Proteomic. 2004 Aug;3(2):125-41
pubmed: 15355595
Cancer Res. 2008 Jan 1;68(1):73-80
pubmed: 18172298

Auteurs

Benjamin M Greulich (BM)

Department of Biology, Mercer University, Macon, Georgia, USA.

Saranya Rajendran (S)

Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana, USA.

Nicholas F Downing (NF)

Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana, USA.

Taylor R Nicholas (TR)

Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana, USA.

Peter C Hollenhorst (PC)

Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana, USA. Electronic address: pchollen@iu.edu.

Classifications MeSH